Quick Answer
Phathom Pharmaceuticals, Inc. reported Gross Profit of $152.51 million for fiscal year 2025.
Phathom Pharmaceuticals, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $152.51M | +222.6% |
| 2024 | $47.28M | +9080.4% |
| 2023 | $515.0K | — |
| 2022 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $43.31M | +209.5% | +25.7% |
| June 30, 2025 | $34.47M | +479.4% | +39.0% |
| March 31, 2025 | $24.80M | +1568.6% | +77.2% |
| September 30, 2024 | $14.00M | — | +135.3% |
| June 30, 2024 | $5.95M | — | +300.3% |
| March 31, 2024 | $1.49M | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- Phathom Pharmaceuticals, Inc. showed an increase of +222.6% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from Phathom Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: